Myriad Genetics, Inc. Profile Avatar - Palmy Investing

Myriad Genetics, Inc.

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health …

Medical - Diagnostics & Research
US, Salt Lake City [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Myriad Genetics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Myriad Genetics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Myriad Genetics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of MYGN's Analysis
CIK: 899923 CUSIP: 62855J104 ISIN: US62855J1043 LEI: - UEI: -
Secondary Listings
MYGN has no secondary listings inside our databases.